Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neuronaute

K-Number: K202334 · 2020-12-10

Decision Date2020-12-10
Product CodeGWQ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Neuronaute is the device name listed in this FDA 510(k) record. The listed applicant is Bioserenity Sas. It received FDA 510(k) clearance on 2020-12-10 under 510(k) number K202334. The device is classified under product code GWQ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neuronaute?

Neuronaute is a medical device that received FDA 510(k) clearance on 2020-12-10. The listed applicant is Bioserenity Sas. The 510(k) number is K202334.

When did Neuronaute receive FDA 510(k) clearance?

Neuronaute received FDA 510(k) clearance on 2020-12-10, under 510(k) number K202334.

Who is the listed applicant for Neuronaute?

The FDA 510(k) record lists Bioserenity Sas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Neuronaute?

The FDA product code for Neuronaute is GWQ.

Other records listing Bioserenity Sas as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GWQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.